Molecular Testing in Thyroid Cancer
0 Visualizações
• 07/01/23
0
0
Embutir
administrator
Assinantes
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários